Cargando…
Dihydromyricetin Reduced Bcl-2 Expression via p53 in Human Hepatoma HepG2 Cells
Dihydromyricetin (DHM) is a major active ingredient of flavonoids compounds. It exhibited anticancer activity and induced apoptosis in human hepatocellular carcinoma HepG2 cells according to our previous data. In this study, we investigated whether p53 is involved in DHM-triggered viability inhibiti...
Autores principales: | Wu, Shixing, Liu, Bin, Zhang, Qingyu, Liu, Jie, Zhou, Wei, Wang, Chang, Li, Mingyi, Bao, Shiting, Zhu, Runzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817187/ https://www.ncbi.nlm.nih.gov/pubmed/24223706 http://dx.doi.org/10.1371/journal.pone.0076886 |
Ejemplares similares
-
Diosmetin induces apoptosis by upregulating p53 via the TGF-β signal pathway in HepG2 hepatoma cells
por: LIU, BIN, et al.
Publicado: (2016) -
Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway
por: LIU, BIN, et al.
Publicado: (2015) -
Dihydromyricetin-mediated inhibition of the Notch1 pathway induces apoptosis in QGY7701 and HepG2 hepatoma cells
por: Lu, Cai-Jie, et al.
Publicado: (2017) -
Dihydromyricetin Enhances the Chemo-Sensitivity of Nedaplatin via Regulation of the p53/Bcl-2 Pathway in Hepatocellular Carcinoma Cells
por: Jiang, Lianggui, et al.
Publicado: (2015) -
Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cells
por: Qiao, Jie, et al.
Publicado: (2016)